• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性乳腺癌患者与外科医生的体验:MaleWhySurg 研究。

Male Breast Cancer Patient and Surgeon Experience: The Male WhySurg Study.

机构信息

Department of Surgery, NorthShore University HealthSystem, Evanston, IL, USA.

Department of Surgery, Pritzker School of Medicine at University of Chicago, Chicago, IL, USA.

出版信息

Ann Surg Oncol. 2022 Oct;29(10):6115-6131. doi: 10.1245/s10434-022-12135-6. Epub 2022 Jul 25.

DOI:10.1245/s10434-022-12135-6
PMID:35876929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9310362/
Abstract

BACKGROUND

Little is known about the experience of the male breast cancer patient. Mastectomy is often offered despite evidence that breast-conserving surgery (BCS) provides similar outcomes.

METHODS

Two concurrent online surveys were distributed from August to October 2020 via social media to male breast cancer (MBC) patients and by email to American Society of Breast Surgeon members. The MBC patients were asked their opinions about their surgery, and the surgeons were asked to provide surgical recommendations for MBC patients.

RESULTS

The survey involved 63 MBC patients with a mean age of 62 years (range, 31-79 years). Five MBC patients (7.9 %) stated that their surgeon recommended BCS, but 54 (85.7 %) of the patients underwent unilateral, and 8 (12.7 %) underwent bilateral mastectomy. Most of the patients (n = 60, 96.8 %) had no reconstruction. One third of the patients (n = 21, 33.3 %) felt somewhat or very uncomfortable with their appearance after surgery. The response rate was 16.5 % for the surgeons. Of the 438 surgeons who answered the survey, 298 (73.3 %) were female, 215 (51.7 %) were fellowship-trained, and 244 (58.9 %) had been practicing for 16 years or longer. More than half of surgeons (n = 259, 59.1 %) routinely offered BCS to eligible men, and 180 (41.3 %) stated they had performed BCS on a man with breast cancer. Whereas 89 (20.8 %) of the surgeons stated that they routinely offer reconstruction to MBC patients, 87 (20.3 %) said they do not offer reconstruction, 96 (22.4 %) said they offer it only if the patient requests it, and 157 (36.6 %) said they never consider it as an option.

CONCLUSIONS

The study found discordance between MBC patients' satisfaction with their surgery and surgeon recommendations and experience. These data present an opportunity to optimize the MBC patient experience.

摘要

背景

男性乳腺癌患者的体验鲜为人知。尽管有证据表明保乳手术(BCS)提供了相似的结果,但仍常建议进行乳房切除术。

方法

2020 年 8 月至 10 月,通过社交媒体向男性乳腺癌(MBC)患者和美国乳腺外科医生协会成员的电子邮件同时分发了两份在线调查。MBC 患者被问及他们对手术的看法,外科医生被要求为 MBC 患者提供手术建议。

结果

该调查涉及 63 名平均年龄为 62 岁(范围,31-79 岁)的 MBC 患者。有 5 名 MBC 患者(7.9%)表示他们的外科医生建议进行 BCS,但 54 名(85.7%)患者接受了单侧乳房切除术,8 名(12.7%)患者接受了双侧乳房切除术。大多数患者(n=60,96.8%)没有进行重建。有三分之一的患者(n=21,33.3%)对手术后的外观感到有些或非常不舒服。外科医生的回复率为 16.5%。在回答调查的 438 名外科医生中,298 名(73.3%)为女性,215 名(51.7%)接受过专科培训,244 名(58.9%)从业时间在 16 年或以上。超过一半的外科医生(n=259,59.1%)通常向符合条件的男性提供 BCS,180 名(41.3%)表示他们曾为患有乳腺癌的男性进行过 BCS。虽然 89 名(20.8%)外科医生表示他们通常向 MBC 患者提供重建,但 87 名(20.3%)表示他们不提供重建,96 名(22.4%)表示他们仅在患者要求时提供,而 157 名(36.6%)表示他们从未将其视为一种选择。

结论

研究发现,MBC 患者对手术的满意度与其外科医生的建议和经验之间存在差异。这些数据为优化 MBC 患者体验提供了机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7b6/9310362/d7ac9daceb0b/10434_2022_12135_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7b6/9310362/d7ac9daceb0b/10434_2022_12135_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7b6/9310362/d7ac9daceb0b/10434_2022_12135_Fig1_HTML.jpg

相似文献

1
Male Breast Cancer Patient and Surgeon Experience: The Male WhySurg Study.男性乳腺癌患者与外科医生的体验:MaleWhySurg 研究。
Ann Surg Oncol. 2022 Oct;29(10):6115-6131. doi: 10.1245/s10434-022-12135-6. Epub 2022 Jul 25.
2
Surgeon recommendations and receipt of mastectomy for treatment of breast cancer.外科医生的建议及乳腺癌治疗中乳房切除术的接受情况。
JAMA. 2009 Oct 14;302(14):1551-6. doi: 10.1001/jama.2009.1450.
3
Surgeons’ Recommendation is the Factor in Determining the Breast Cancer Surgery Procedures: an Experience from Rural Hospital in Thailand.外科医生的建议是决定乳腺癌手术方式的因素:泰国一家乡村医院的经验。
Asian Pac J Cancer Prev. 2018 May 26;19(5):1189-1193. doi: 10.22034/APJCP.2018.19.5.1189.
4
Surgeon perspectives about local therapy for breast carcinoma.外科医生对乳腺癌局部治疗的观点。
Cancer. 2005 Nov 1;104(9):1854-61. doi: 10.1002/cncr.21396.
5
Breast conserving surgery versus mastectomy: cancer practice by general surgeons in Iran.保乳手术与乳房切除术:伊朗普通外科医生的癌症治疗实践
BMC Cancer. 2005 Apr 5;5:35. doi: 10.1186/1471-2407-5-35.
6
Patients Undergoing Bilateral Mastectomy and Breast-Conserving Surgery Have the Lowest Levels of Regret: The WhySurg Study.接受双侧乳房切除术和保乳手术的患者后悔程度最低:WhySurg 研究。
Ann Surg Oncol. 2021 Oct;28(10):5686-5697. doi: 10.1245/s10434-021-10452-w. Epub 2021 Aug 25.
7
Re-excision and survival following breast conserving surgery in early stage breast cancer patients: a population-based study.早期乳腺癌患者保乳手术后的再次切除与生存情况:一项基于人群的研究。
BMC Health Serv Res. 2018 Feb 8;18(1):94. doi: 10.1186/s12913-018-2882-7.
8
Surgical treatment of early breast cancer: what would surgeons choose for themselves?早期乳腺癌的手术治疗:外科医生会为自己选择什么?
Eff Clin Pract. 1999 Jul-Aug;2(4):149-51.
9
Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial.非临床试验中早期乳腺癌女性不同治疗策略的心理结局
BMJ. 1990 Sep 22;301(6752):575-80. doi: 10.1136/bmj.301.6752.575.
10
Localized therapy for male breast cancer: functional advantages with comparable outcomes using breast conservation.男性乳腺癌的局部治疗:保乳治疗具有可比结局下的功能优势。
Clin Breast Cancer. 2013 Oct;13(5):344-9. doi: 10.1016/j.clbc.2013.05.004. Epub 2013 Jul 26.

引用本文的文献

1
Survival impact of adjuvant radiotherapy in early stage low risk elderly male breast cancer patients treated with breast conserving surgery.保乳手术治疗的早期低风险老年男性乳腺癌患者辅助放疗的生存影响
Sci Rep. 2025 Aug 24;15(1):31108. doi: 10.1038/s41598-025-17083-1.
2
Experiences and perceptions of men following breast cancer diagnosis: a mixed method systematic review.男性乳腺癌诊断后的体验和看法:一项混合方法系统评价。
BMC Cancer. 2024 Feb 6;24(1):179. doi: 10.1186/s12885-024-11911-9.
3
Development and validation of nomograms to predict the survival probability and occurrence of a second primary malignancy of male breast cancer patients: a population-based analysis.

本文引用的文献

1
Male Breast Cancer Review. A Rare Case of Pure DCIS: Imaging Protocol, Radiomics and Management.男性乳腺癌综述。一例罕见的单纯导管原位癌病例:成像方案、放射组学与管理
Diagnostics (Basel). 2021 Nov 25;11(12):2199. doi: 10.3390/diagnostics11122199.
2
Treatment of male breast cancer: meta-analysis of real-world evidence.男性乳腺癌的治疗:真实世界证据的荟萃分析。
Br J Surg. 2021 Sep 27;108(9):1034-1042. doi: 10.1093/bjs/znab279.
3
Patients Undergoing Bilateral Mastectomy and Breast-Conserving Surgery Have the Lowest Levels of Regret: The WhySurg Study.
预测男性乳腺癌患者生存概率及发生第二原发性恶性肿瘤的列线图的开发与验证:一项基于人群的分析
Front Oncol. 2023 Apr 20;13:1076997. doi: 10.3389/fonc.2023.1076997. eCollection 2023.
4
23rd Annual Meeting of the American Society of Breast Surgeons: Back to In-Person Scientific Exploration.美国乳腺外科医生协会第23届年会:回归面对面科学探索。
Ann Surg Oncol. 2022 Oct;29(10):6087-6089. doi: 10.1245/s10434-022-12263-z. Epub 2022 Jul 28.
接受双侧乳房切除术和保乳手术的患者后悔程度最低:WhySurg 研究。
Ann Surg Oncol. 2021 Oct;28(10):5686-5697. doi: 10.1245/s10434-021-10452-w. Epub 2021 Aug 25.
4
Passing as normal: Negotiating boundaries and coping with male breast cancer.正常化的过程:协商边界和应对男性乳腺癌。
Soc Sci Med. 2021 Sep;284:114239. doi: 10.1016/j.socscimed.2021.114239. Epub 2021 Jul 17.
5
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
6
Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: a systematic review and meta-analysis.乳腺癌幸存者中乳房重建与全乳房切除术和保乳手术的健康相关生活质量比较:系统评价和荟萃分析。
Breast Cancer. 2020 Jul;27(4):534-566. doi: 10.1007/s12282-020-01076-1. Epub 2020 Mar 12.
7
Association of Germline Genetic Testing Results With Locoregional and Systemic Therapy in Patients With Breast Cancer.遗传性基因检测结果与乳腺癌患者局部区域和全身治疗的相关性。
JAMA Oncol. 2020 Apr 1;6(4):e196400. doi: 10.1001/jamaoncol.2019.6400. Epub 2020 Apr 9.
8
Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century.美国男性乳腺癌:21 世纪的治疗模式和预后因素。
Cancer. 2020 Jan 1;126(1):26-36. doi: 10.1002/cncr.32472. Epub 2019 Oct 7.
9
Breast Cancer Screening in High-Risk Men: A 12-year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes.高危男性的乳腺癌筛查:男性乳腺影像学应用和结果的 12 年纵向观察性研究。
Radiology. 2019 Nov;293(2):282-291. doi: 10.1148/radiol.2019190971. Epub 2019 Sep 17.
10
Validation of Patient-Reported Outcomes: A Low Bar.患者报告结局的验证:标准很低。
J Clin Oncol. 2019 Aug 10;37(23):1990-1992. doi: 10.1200/JCO.19.01126. Epub 2019 Jun 26.